sibutramine (Compound)

Synonyms:sibutramine, 106650-56-0, Medaria, Sibutraminum [Latin], Sibutramina [Spanish], Butramin, (+/-)-Sibutramine, racemic sibutramine, 1-[1-(4-chlorophenyl)cyclobutyl]-N,N,3-trimethylbutan-1-amine, Cf-alli, Sibutramine (INN), CHEBI:9137, Sibutraminum, WV5EC51866, Sibutramina, SIBUTRAMINE [INN], Sibutramine [INN:BAN], Butramin (TN), SMR000238156, (R)-DDMS, UNII-WV5EC51866, DEA No. 1675, BTS 54 524, Spectrum_001961, SIBUTRAMINE [MI], Spectrum2_001686, Spectrum3_001009, Spectrum4_001137, Spectrum5_001440, SIBUTRAMINE [VANDF], SCHEMBL2955, CHEMBL1419, BSPBio_002737, KBioGR_001653, KBioSS_002516, SIBUTRAMINE [WHO-DD], MLS001066619, MLS001401362, SPBio_001612, GTPL2586, DTXSID1023578, BDBM84742, HSDB 7209, KBio2_002508, KBio2_005076, KBio2_007644, KBio3_001957, HMS2052P05, HMS2090N17, HMS2272C06, HMS3394P05, BCP08127, NSC_5210, BBL010956, STK802066, AKOS004119970, AKOS022060500, CCG-101166, DB01105, NC00416, Cyclobutanemethanamine, 1-(4-chlorophenyl)-N,N-dimethyl-alpha-(2-methylpropyl)-, NCGC00092357-02, NCGC00092357-04, ( inverted exclamation markA)-Sibutramine, AC-15773, SBI-0206737.P001, CAS_106650-56-0, FT-0674580, C07247, D08513, AB00949538-11, AB00949538_12, Q424151, {1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl}dimethylamine, (+/-)-1-(P-CHLOROPHENYL)-.ALPHA.-ISOBUTYL-N,N-DIMETHYLCYCLOBUTANEMETHYLAMINE, (.+/-.)-1-(p-Chlorophenyl)-.alpha.-isobutyl-N,N-dimethylcyclobutanemethylamine, 1-(4-CHLOROPHENYL)-N,N-DIMETHYL-.ALPHA.-(2-METHYLPROPYL)CYCLOBUTANEMETHANAMINE, CYCLOBUTANEMETHANAMINE, 1-(4-CHLOROPHENYL)-N,N-DIMETHYL-.ALPHA.-(2-METHYLPROPYL)-

Pubchem:PUBCHEM:5210

Id:860fbea6-46dd-5379-a157-11cf8a7178b7

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View sibutramine's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for sibutramine.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with sibutramine.

Results found

Linked to

	Label	Description
	BRD-A23359898-003-11-8 Substance (Entity type)	A Substance
	sibutramine (15aff1a7-8fed-40f4-af97-2cbfe23ec059) Collection (Entity type)	Metadatata for sibutramine
	DCSTRUCT ID 02440 Collection (Entity type)	DrugPage Collection: (DrugCentralID:02440; PubChem_CID:5210, FILE=drugcentral_drug_02440.json)
	sibutramine positively regulates GULP1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	SID11113615 in similarity relationship with sibutramine Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	sibutramine positively regulates FBP1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	sibutramine positively regulates TBX3 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	sibutramine negatively regulates MT1E Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	sibutramine negatively regulates EIF1AY Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	sibutramine negatively regulates IFI27 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS